Ligand validation:8IRH

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IRH_HTG_B_624	81%	42%	0.094	0.945	1.17	1.14	2	2	0	0	100%	1
8IRH_HTG_b_624	64%	36%	0.117	0.917	1.02	1.56	2	3	0	0	100%	1
8IRH_HTG_B_621	41%	36%	0.156	0.872	1.03	1.55	2	5	0	0	100%	1
8IRH_HTG_b_621	39%	23%	0.166	0.873	1.26	2.09	2	7	0	0	100%	1
8IRH_HTG_B_622	28%	40%	0.214	0.865	0.82	1.55	1	2	0	0	100%	1
8IRH_HTG_c_522	14%	37%	0.288	0.841	0.93	1.59	1	3	0	0	100%	1
8IRH_HTG_C_522	9%	43%	0.337	0.824	0.87	1.39	1	2	0	0	100%	1
8IRH_HTG_d_411	7%	37%	0.287	0.764	0.97	1.59	1	2	0	0	84%	0.8421
8IRH_HTG_V_202	6%	62%	0.436	0.94	0.32	1.1	-	1	0	0	58%	0.5789
8IRH_HTG_D_410	4%	37%	0.281	0.689	1	1.56	1	1	0	0	84%	0.8421
8IRH_HTG_b_622	1%	32%	0.463	0.663	0.99	1.78	1	3	0	0	100%	1
5V2C_HTG_O_303	94%	35%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	38%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	38%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	37%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	46%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.